Evidence map›Paper›PMID 30568043›Full record

ArticleJCI insight2018

Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle function.

Xiao-Yan Wen, Maja Tarailo-Graovac, Koroboshka Brand-Arzamendi, Anke Willems, Bojana Rakic, Karin Huijben, Afitz Da Silva, Xuefang Pan, Suzan El-Rass, Robin Ng and 21 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. CD21Frontiers in immunology · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Science advances · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 8 institutions in 3 countries.

Xiao-Yan WenZebrafish Centre for Advanced Drug Discovery and Keenan Research Centre for Biomedical science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
Maja Tarailo-GraovacDepartment of Medical Genetics and Department of Pathology and Laboratory Sciences, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada.
Koroboshka Brand-ArzamendiZebrafish Centre for Advanced Drug Discovery and Keenan Research Centre for Biomedical science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
Anke WillemsDepartment of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, Netherlands.
Bojana RakicDepartment of Medical Genetics and Department of Pathology and Laboratory Sciences, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada.
Karin HuijbenTranslational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
Afitz Da SilvaSainte-Justine University Hospital Research Center, University of Montreal, Montreal, Quebec, Canada.
Xuefang PanSainte-Justine University Hospital Research Center, University of Montreal, Montreal, Quebec, Canada.
Suzan El-RassZebrafish Centre for Advanced Drug Discovery and Keenan Research Centre for Biomedical science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
Robin NgZebrafish Centre for Advanced Drug Discovery and Keenan Research Centre for Biomedical science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
Katheryn SelbyDepartment of Medical Genetics and Department of Pathology and Laboratory Sciences, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada.
Anju Mary PhilipZebrafish Centre for Advanced Drug Discovery and Keenan Research Centre for Biomedical science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
Junghwa YunZebrafish Centre for Advanced Drug Discovery and Keenan Research Centre for Biomedical science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
X Cynthia YeDepartment of Medical Genetics and Department of Pathology and Laboratory Sciences, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada.
Colin J RossDepartment of Medical Genetics and Department of Pathology and Laboratory Sciences, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada.
Anna M LehmanDepartment of Medical Genetics and Department of Pathology and Laboratory Sciences, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada.
Fokje ZijlstraTranslational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
N Abu BakarDepartment of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, Netherlands.
Britt DrögemöllerFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver Canada.
Jacqueline MorelandDepartments of Biochemistry, Molecular Biology, and Medical Genetics, Cumming School of Medicine, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Canada.
Wyeth W WassermanDepartment of Medical Genetics and Department of Pathology and Laboratory Sciences, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada.
Hilary VallanceDepartment of Medical Genetics and Department of Pathology and Laboratory Sciences, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada.
Monique van ScherpenzeelDepartment of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, Netherlands.
Farhad KarbassiZebrafish Centre for Advanced Drug Discovery and Keenan Research Centre for Biomedical science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
Martin HoskingsDepartment of Pediatrics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver Canada.
Udo EngelkeTranslational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
Arjan de BrouwerDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, Netherlands.
Ron A WeversTranslational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
Alexey V PshezhetskySainte-Justine University Hospital Research Center, University of Montreal, Montreal, Quebec, Canada.
Clara Dm van KarnebeekCentre for Molecular Medicine and Therapeutics, Vancouver, British Columbia, Canada.
Dirk J LefeberDepartment of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, Netherlands.
Radboud University Nijmegen · NLSt. Michael's Hospital · CABC Children's Hospital · CAPacific Centre for Reproductive Medicine · CAAlberta Children's Hospital · CAUniversité de Montréal · CAMcGill University · CAUniversity of British Columbia · CA

Funding

CIHR 301221CIHR PJT-148863
6 · The paper itself

Abstract

Sialic acids are important components of glycoproteins and glycolipids essential for cellular communication, infection, and metastasis. The importance of sialic acid biosynthesis in human physiology is well illustrated by the severe metabolic disorders in this pathway. However, the biological role of sialic acid catabolism in humans remains unclear. Here, we present evidence that sialic acid catabolism is important for heart and skeletal muscle function and development in humans and zebrafish. In two siblings, presenting with sialuria, exercise intolerance/muscle wasting, and cardiac symptoms in the brother, compound heterozygous mutations [chr1:182775324C>T (c.187C>T; p.Arg63Cys) and chr1:182772897A>G (c.133A>G; p.Asn45Asp)] were found in the N-acetylneuraminate pyruvate lyase gene (NPL). In vitro, NPL activity and sialic acid catabolism were affected, with a cell-type-specific reduction of N-acetyl mannosamine (ManNAc). A knockdown of NPL in zebrafish resulted in severe skeletal myopathy and cardiac edema, mimicking the human phenotype. The phenotype was rescued by expression of wild-type human NPL but not by the p.Arg63Cys or p.Asn45Asp mutants. Importantly, the myopathy phenotype in zebrafish embryos was rescued by treatment with the catabolic products of NPL: N-acetyl glucosamine (GlcNAc) and ManNAc; the latter also rescuing the cardiac phenotype. In conclusion, we provide the first report to our knowledge of a human defect in sialic acid catabolism, which implicates an important role of the sialic acid catabolic pathway in mammalian muscle physiology, and suggests opportunities for monosaccharide replacement therapy in human patients.

Indexed as

AdultAnimalsDisease Models, AnimalEdema, CardiacGene Expression Regulation, DevelopmentalGene Knockdown TechniquesGenetic Diseases, InbornHEK293 CellsHexosaminesHumansMaleMuscle, SkeletalMuscular DiseasesMutationN-Acetylneuraminic AcidOxo-Acid-LyasesHexosaminesmannosamineN-acetylneuraminate lyaseN-Acetylneuraminic AcidOxo-Acid-LyasesGenetic diseasesGeneticsMetabolismMolecular biologySkeletal muscle

Identifiers

PMID30568043
PMCPMC6338320
OpenAlexW2903633028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.